2026 — Wirth & Scheibenbogen — excitatory/inhibitory neurotransmitter imbalance + skeletal-muscle calcium overload in ME/CFS
One-paragraph summary
Comprehensive review by the authors of the 2020 vasoconstrictive-ME/CFS-subtype framework, extending it across four neurotransmitter systems — noradrenergic, serotonergic, GABAergic, and glutamatergic — as a unifying account of ME/CFS and post-COVID syndrome symptom overlap (severe fatigue, cognitive dysfunction, exertional intolerance, sleep disturbances, hypervigilance, "wired but tired"). Contributing upstream factors named: autoimmunity, neuroinflammation, gut dysbiosis, epigenetic influences, and stressors. Key mechanistic chain: reduced GABAergic tone + elevated glutamatergic + elevated noradrenergic activity → elevated skeletal muscle tone → calcium overload → mitochondrial dysfunction → exertional intolerance / post-exertional malaise (PEM). The chain converges on mitochondrial dysfunction as a downstream effector, with skeletal-muscle calcium overload as the proximate driver. Various pharmacological treatments partially rebalance the neurotransmitter systems but with limited efficacy, motivating the need for systematic stratified investigation. For the project, this paper provides a candidate fifth upstream entry to H1's mtDNA-cGAS-STING positive-feedback amplifier (alongside HERV-W ENV via circ_0001810/AK2, microglial P2X7 stress, possibly SARS-CoV-2 LINE-1 integration, and oxidative stress per Xu 2026 Tempol): if skeletal-muscle calcium overload drives mitochondrial dysfunction → mtDNA release → cGAS-STING activation, this is a neurotransmitter-substrate-driven upstream entry distinct from viral/genomic/oxidative mechanisms. Directly addresses Q59 — the Wirth & Scheibenbogen framework is the comparison point for Azcue 2026's β2-AR-elevated ME/CFS subset.
Claims as triples
excitatory_inhibitory_neurotransmitter_imbalance — present_in → me_cfs[evidence: comprehensive review citing multiple lines; confidence: emerging]excitatory_inhibitory_neurotransmitter_imbalance — present_in → post_covid_syndrome[evidence: shared symptom profile + neurotransmitter studies; confidence: emerging]GABA_deficiency — causes → elevated_skeletal_muscle_tone[evidence: GABAergic-tone-loss mechanism review; confidence: bridging]glutamatergic_hyperactivity — causes → elevated_skeletal_muscle_tone[evidence: same; confidence: bridging]skeletal_muscle_calcium_overload — causes → mitochondrial_dysfunction[evidence: muscle-physiology mechanism; confidence: emerging]mitochondrial_dysfunction — causes → exertional_intolerance[evidence: muscle-energetics framework; confidence: established]mitochondrial_dysfunction — causes → post_exertional_malaise[evidence: same; confidence: emerging]noradrenergic_hyperactivity — causes → sympathetic_hyperactivity[evidence: established cross-reference; confidence: established]autoimmunity — drives → excitatory_inhibitory_neurotransmitter_imbalance[evidence: review mechanism citation; confidence: bridging]
Triangulation notes
- Candidate fifth upstream entry to H1's mtDNA-cGAS-STING amplifier. The H1 loop currently lists four upstream drivers: HERV-W ENV via circ_0001810/AK2 (Oltra 2023, Koo & Morrow 2025), microglial P2X7 under chronic stress (He 2026), possibly SARS-CoV-2 LINE-1 integration (Zhang & Jaenisch 2021), oxidative stress / ROS (Xu 2026 Tempol). Wirth & Scheibenbogen 2026 adds: neurotransmitter-imbalance-driven skeletal-muscle calcium overload → mitochondrial dysfunction → mtDNA release → cGAS-STING activation. The chain redundancy property of H1 strengthens further; the amplifier accepts upstream input from yet another mechanistic axis.
- Directly addresses Q59 (does the Azcue 2026 β2-AR-elevated ME/CFS subset overlap with vasoconstrictive-ME/CFS-subtype findings?). The β2-adrenergic AAbs Azcue measured are functional agonists at adrenergic receptors — exactly the noradrenergic-hyperactivity driver Wirth & Scheibenbogen frame as one of three excitatory hyperactivity sources. The β2-AR-AAb-positive ME/CFS subset is plausibly the same subset Wirth & Scheibenbogen describe as having reduced vagal tone / sympathetic hyperactivity. Bridge from the autoantibody-profile layer to the neurotransmitter-imbalance layer.
- Connects to the §12.6 MCAS-stratified cromolyn arm. Mast-cell mediators include histamine (which modulates noradrenergic tone) and serotonin — the H2 residual MC subset framing could be reframed as MC mediators contributing to the Wirth & Scheibenbogen neurotransmitter imbalance rather than operating as an independent chain. Reinforces v0.3's reframing of H2-MC as subsumed.
- Cross-pharmacology cure-path-arm candidates. GABAergic agonists (clinical-grade benzodiazepines, baclofen, gabapentin/pregabalin), glutamatergic antagonists (memantine, ketamine — see B27 bridge), and noradrenergic dampeners (clonidine, propranolol, prazosin) become candidate neurotransmitter-rebalancing arms. Most are already FDA-approved for other indications — repurposing-tier candidates if stratification can identify the imbalance subset.
- Mitochondrial-protective agents become more cross-cutting. Idebenone, MitoQ, elamipretide, and Tempol now sit at the convergence point of FIVE different upstream pathways — they're mechanistically agnostic to which upstream driver is active in a given patient, making them the most chain-redundant intervention class in the project.
Open questions raised
- Does the Azcue 2026 β2-AR-AAb-elevated ME/CFS subset overlap with the Wirth & Scheibenbogen sympathetic-hyperactive subset at the patient level? (Direct extension of Q59.)
- Is skeletal-muscle cell-free mtDNA elevated in PEM-active ME/CFS patients, and does it correlate with the ISG signature? (Direct test of the Wirth & Scheibenbogen → H1 amplifier connection.)
- Do clonidine + low-dose memantine + low-dose GABA-agonist combinations rebalance neurotransmitter tone in stratified ME/CFS / FM patients? (Multi-arm neurotransmitter-rebalancing pilot.)
- Does FM with prominent exertional intolerance show the same skeletal-muscle calcium-overload mechanism as ME/CFS, or is the exertional-intolerance overlap convergent rather than mechanistically shared?